Patent · US Active

Number of IL4 and/or IL13 secreting T-cells as a biomarker for allergic diseases

US10006903B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignees

Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
UNIVERSITE DE PARIS DESCARTES · FR
ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS (APHP) · FR
Universite Pierre Et Marie Curie (Paris 6) · FR

Inventors

Jocelyne Just · Paris, FR
Benedicte Michaud · Paris, FR
Jean-Francois Bach · Paris, FR
Lucienne Chatenoud · Paris, FR

Key dates

Filing date	Jul 22, 2014
Grant date	Jun 26, 2018
Priority date	—
Expiry date	Mar 13, 2035

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/24
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to an in vitro use of a number of IL-4 and/or IL-13 secreting T-cells as a biomarker for diagnosing and/or monitoring an IgE-dependent allergic disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.